![Study suggests Covid rebound is far more common with Paxlovid than without | The Transmission | University of Nebraska Medical Center Study suggests Covid rebound is far more common with Paxlovid than without | The Transmission | University of Nebraska Medical Center](https://www.unmc.edu/healthsecurity/transmission/wp-content/uploads/2023/11/Screenshot-2023-11-14-at-16.34.24.png)
Study suggests Covid rebound is far more common with Paxlovid than without | The Transmission | University of Nebraska Medical Center
![COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure | University of California COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure | University of California](https://www.universityofcalifornia.edu/sites/default/files/styles/article_default_banner/public/paxlovid.jpeg?h=602a36b5&itok=JDbqYUxp)
COVID-19 rebound after taking Paxlovid likely due to insufficient drug exposure | University of California
![CDC warns of COVID-19 "rebound" after taking Paxlovid antiviral, but says drug still beneficial - CBS News CDC warns of COVID-19 "rebound" after taking Paxlovid antiviral, but says drug still beneficial - CBS News](https://assets3.cbsnewsstatic.com/hub/i/r/2022/05/30/53349df6-b00a-4e40-8ad7-1c4bd0c8f904/thumbnail/1200x630/d7dabe613fd2e04023759b762377e21b/gettyimages-1238868394.jpg?v=57e8fa9efcf044a821348136ff26ed69)
CDC warns of COVID-19 "rebound" after taking Paxlovid antiviral, but says drug still beneficial - CBS News
![Physicians say they need clearer guidance on prescribing Paxlovid amid concerns around COVID-19 rebound | PBS NewsHour Physicians say they need clearer guidance on prescribing Paxlovid amid concerns around COVID-19 rebound | PBS NewsHour](https://d3i6fh83elv35t.cloudfront.net/static/2022/05/2022-05-28T110526Z_1754196248_RC2MFS9OUV8U_RTRMADP_3_HEALTH-CORONAVIRUS-TREATMENTS-PFIZER-1024x683.jpg)